Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rituximab: Don't Count It Out as MS Treatment
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
22nd Meeting of European Neurological Society
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
The International Symposium on the Multiple Sclerosis Brain
Keystone Symposium on Growing to Extremes: Cell Biology and Pathology of Axons
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Gilenya prescribing information
Development of the Brief Inventory of Perceived Stress.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Pages